目的探讨瑞舒伐他汀对慢性肾病患者抗炎疗效。
Objective to explore the anti-inflammatory effect of rosuvastatin on chronic kidney disease (CKD) patients.
健康人使用瑞舒伐他汀能够降低心脏疾病的风险。
Rosuvastatin appears to lower the risk of heart disease in healthy people.
结论：瑞舒伐他汀可有效治疗老年冠心病阵发性房颤。
Conclusion: Rosuvastatin can effective treatment the elderly people which has coronary heart disease with paroxysmal atrial fibrillation.
结论瑞舒伐他汀对改善脑梗塞患者脑血流动力学有一定的作用。
Conclusion Rosuvastatin may have the effects on improving the situation of cerebral haemodynamics of patients with ischemic stroke.
目的观察瑞舒伐他汀和阿托伐他汀对氯吡格雷抗血小板活性的影响。
Objective to observe the influence of rosuvastatin or atorvastatin on platelet aggregation in patients treated with clopidogrel.
本发明属医药领域，具体涉及一种瑞舒伐他汀钙的片剂及其制备工艺。
The invention belongs to the filed of medicine, in particular to a tablet containing Rosuvastatin calcium and a preparation process thereof.
常规剂量应用瑞舒伐他汀患者耐受好，不会引起严重的肝脏或肌肉损害。
Patients can well tolerate the conventional dose of rosuvastatin, and can't have serious liver or muscle damage with such dose.
欧洲心脏病学会最近发布的一项临床试验采用了瑞舒伐他汀，可惜结果显示无效。
It was trial that was presented recently at the European society of cardiology that showed unfortunately in this particular case statinst called rosuvastatin didn't work.
目的：探讨瑞舒伐他汀对高脂血症患者补体、补体调节蛋白及主动脉脉搏波速度的影响。
Objective to investigate the effect of rosuvastatin on complement, complement regulatory proteins and aortic pulse wave velocity in patients with hyperlipidemia.
结论在常规治疗冠心病方法的基础上服用瑞舒伐他汀，可以降低血脂，抑制CRP的产生。
Conclusion on the basis of conventional therapy, the addition of rosuvastatin can reduce blood lipid and inhibit the production of CRP in coronary heart disease.
结论：瑞舒伐他汀与依折麦布联合使用，降脂效果明显，疗效好，不良反应少，是理想的降脂方案。
Conclusion rosuvastatin and ezetimibe combination lipid-lowering effect is obvious, good efficacy, adverse reactions, is the ideal lipid-lowering program.
《国际循环》：您的数据提示女性患者对瑞舒伐他汀的疗效反应较阿托伐他汀更好，如何解释这一结果？
International Circulation: Your data shows that the female subgroup had a better response to rosuvastatin than to atorvastatin. Do you have an explanation for that?
现在我们拥有了瑞舒伐他汀，我认为未来我们会更多地使用较高剂量的瑞舒伐他汀以更有效地降低LDL - C。
Now we have rosuvastatin. I think in the future we will see more relatively higher dose rosuvastatin being employed to lower LDLc.
现在我们拥有了瑞舒伐他汀，我认为未来我们会更多地使用较高剂量的瑞舒伐他汀以更有效地降低LDL - C。
Now we have rosuvastatin. I think in the future we will see more relatively higher dose rosuvastatin being employed to lower LDLc.
应用推荐